Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus

Archives of Dermatology

Volumn 135, Issue 8, 1999, Pages 943-947

  Ishii, Ken ^a   Amagai, Masayuki ^a   Komai, Ayako ^c   Ebihara, Tamotsu ^b   Chorzelski, Tadeusz P ^e   Jablonska, Stefania ^e   Ohya, Kazuhiko ^d   Nishikawa, Takeji ^a   Hashimoto, Takashi ^c  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Medical & Biological Laboratories Co Ltd   (Japan)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; DESMOGLEIN;

ARTICLE; AUTOIMMUNE DISEASE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPETIFORM PEMPHIGUS; HUMAN; IMMUNOADSORPTION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KERATINOCYTE; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL;

AUTOANTIGENS; CELL ADHESION MOLECULES; CYTOSKELETAL PROTEINS; DESMOGLEIN 1; DESMOGLEIN 3; DESMOGLEINS; DESMOPLAKINS; HUMANS; IMMUNOGLOBULIN G; PEMPHIGUS;

EID: 0032815420     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.8.943     Document Type: Article

References (27)

1. Stanley JR. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol. 1993;53:291-325.
2. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991;67: 869-877.
3. Amagai M. Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol. 1996;11:319-352.
4. Jablonska S, Chorzelski TP, Beutner EH, Chorselska J. Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol. 1975;14:353-359.
5. DeMento FJ, Grover RW. Acantholytic herpetiform dermatitis. Arch Dermatol. 1973;107:883-887.
6. Seah PP, Fry L, Cairns RJ, et al. Pemphigus controlled by sulphapyridine. Br J Dermatol. 1973;89:77-81.
7. Barranco VP, Okla T. Mixed bullous disease. Arch Dermatol. 1974;110:221-224.
8. Maciejowska E, Jablonska S, Chorzelski TP. Is pemphigus herpetiformis an entity? Int J Dermatol. 1987;26:571-577.
9. Ingber A, Feuerman EJ. Pemphigus with characteristics of dermatitis herpetiformis: a long-term follow-up of five patients. Int J Dermatol. 1986;25:575-579.
10. Pye RJ. Bullous eruption. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology. 5th ed. Oxford, England: Blackwell; 1992:1623-1673.
11. Kinehara M, Nishikawa T. A case of herpetiform pemphigus vulgaris. Jpn J Clin Dermatol. 1979;33:495-498.
12. Verdier SS, Joly P, Thomine E, et al. Thiopronine-induced herpetiform pemphigus: report of a case studied by immunoelectron microscopy and immunoblot analysis. Br J Dermatol. 1994;130:238-240.
13. Shimizu K, Hashimoto T, Wang N, et al. A case of herpetiform pemphigus associated with autoimmune hemolytic anemia: detection of autoantibodies against multiple epidermal antigens. Dermatology. 1996;192:179-182.
14. Santi CG, Maruta CW, Aoki V, Sotto MN, Rivitti EA, Diaz LA. Pemphigus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo selvagem, and pemphigus vulgaris. J Am Acad Dermatol. 1996;34:40-46.
15. Kubo A, Amagai M, Hashimoto T, et al. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3). Br J Dermatol. 1997;137: 109-113.
16. Niizeki H, Konohana I, Ikutomi M, Mita S, Hashimoto T. A case of herpetiform pemphigus. Jpn J Clin Dermatol. 1992;46:831-834.
17. Kikuchi A, Sakuraoka K, Hashimoto T, Nishikawa T, Shiotani C. A case of herpetiform pemphigus. Jpn J Clin Dermatol. 1992;13:1139-1142.
18. Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol. 1995;104:895-901.
19. Amagai M, Hashimoto T, Shimizu N, Nishikawa T. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest. 1994;94:59-67.
20. Ishii K, Amagai M, Hall RP, et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol. 1997;159:2010-2017.
21. Amagai M, Koch PJ, Nishikawa T, Stanley JR. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol. 1996;106:351-355.
22. Hashimoto T, Ogawa MM, Konohana A, Nishikawa T. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol. 1990;94:327-331.
23. Ishii K. Development of ELISAs with recombinant pemphigus antigens expressed by baculovirus. Jpn J Dermatol. 1998;108:937-942.
24. Hashimoto T, Kiyokawa C, Mori O, et al. Human desmocollin (Dsc1) is an autoantigen for the subcorneal pustular dermalosis type of IgA pemphigus. J Invest Dermatol. 1997;109:127-131.
25. Schiltz JR, Michel B. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol. 1976;67: 254-260.
26. Hashimoto K, Shafran KM, Webber PS, Lazarus GS, Singer KH. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. J Exp Med. 1983;157:259-272.
27. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med. 1982;306:1189-1196.